Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Medtronic
AstraZeneca
Baxter
Chinese Patent Office
Cerilliant
Chubb
Farmers Insurance
Accenture

Generated: December 11, 2018

DrugPatentWatch Database Preview

EPANED Drug Profile

« Back to Dashboard

When do Epaned patents expire, and when can generic versions of Epaned launch?

Epaned is a drug marketed by Silvergate Pharms and is included in two NDAs. There are seven patents protecting this drug and two Paragraph IV challenges.

This drug has one patent family member in one country.

The generic ingredient in EPANED is enalapril maleate. There are twenty-seven drug master file entries for this compound. Forty-one suppliers are listed for this compound. Additional details are available on the enalapril maleate profile page.

Drug patent expirations by year for EPANED
Pharmacology for EPANED
Medical Subject Heading (MeSH) Categories for EPANED
Synonyms for EPANED
((S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl)-L-alanyl-L-proline
(2S)-1-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]pyrrolidine-2-carboxylic acid
(2S)-1-[(2S)-2-{[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino}propanoyl]pyrrolidine-2-carboxylic acid
(S,S,S)-1-[2-(1-Ethoxycarbonyl-3-phenyl-propylamino)-propionyl]-pyrrolidine-2-carboxylic acid
(S)-1-((S)-2-(((S)-1-Ethoxy-1-oxo-4-phenylbutan-2-yl)amino)propanoyl)pyrrolidine-2-carboxylic acid
(S)-1-((S)-2-((R)-1-ethoxy-1-oxo-4-phenylbutan-2-ylamino)propanoyl)pyrrolidine-2-carboxylic acid
(S)-1-(N-(1-(Ethoxycarbonyl)-3-phenylpropyl)-L-alanyl)-L-proline
(S)-1-[(R)-2-((R)-1-Ethoxycarbonyl-3-phenyl-propylamino)-propionyl]-pyrrolidine-2-carboxylic acid
(S)-1-[N-[1-(ETHOXYCARBONXYL)-3-PHENYLPROPYL]-L-AL
(S)-1-{(S)-2-[1-((S)-Ethoxycarbonyl)-3-phenyl-propylamino]-propionyl}-pyrrolidine-2-carboxylic acid
(SSS)1-[2-(1-Ethoxycarbonyl-3-phenyl-propylamino)-propionyl]-pyrrolidine-2-carboxylic acid
1-(N-((S)-1-Carboxy-3-phenylpropyl)-L-alanyl)-L-proline 1'-ethyl ester
1-[2-(1-Ethoxycarbonyl-3-phenyl-propylamino)-propionyl]-pyrrolidine-2-carboxylic acid
1-[2-(1-Ethoxycarbonyl-3-phenyl-propylamino)-propionyl]-pyrrolidine-2-carboxylic acid (Enalapril)
1-[2-(1-Ethoxycarbonyl-3-phenyl-propylamino)-propionyl]-pyrrolidine-2-carboxylic acid(enalapril)
172964-46-4
2-[2-(1-Carboxy-3-phenyl-propylamino)-propionyl]-1,2,3,4-tetrahydro-isoquinoline-3-carboxylic acid(enalapril)
69PN84IO1A
75847-73-3
76095-16-4 (maleate)
77549-58-7
847E733
AB00053615_19
AB00053615_20
AB00053615-17
AB00053615-18
AC1NTUS5
AK325516
AKOS025310615
analapril
API0002541
BDBM50017129
BIDD:GT0751
BPBio1_000340
BSPBio_000308
BSPBio_003035
C-21264
C06977
C20H28N2O5
CAS-75847-73-3
CAS-76095-16-4
CC-27456
CHEBI:4784
CHEMBL578
CS-2918
CTK8F9436
D00SEB
D07892
DB00584
DivK1c_000408
DR002110
DSSTox_CID_2982
DSSTox_GSID_22982
DSSTox_RID_76817
DTXSID5022982
Enaladex
enalapril
Enalapril (INN)
Enalapril (TN)
Enalapril [INN:BAN]
Enalapril maleate
Enalapril Maleate Usp Xxi
Enalapril Richet
Enalapril, AldrichCPR
Enalaprila
Enalaprila [INN-Spanish]
Enalaprilum
Enalaprilum [INN-Latin]
GBXSMTUPTTWBMN-XIRDDKMYSA-N
GTPL6322
HE386417
HMS2090E08
HY-B0331
IDI1_000408
K298
KBio1_000408
KBio2_001787
KBio2_004355
KBio2_006923
KBio3_002535
KBioGR_000355
KBioSS_001787
L-Proline, 1-(N-(1-(ethoxycarbonyl)-3-phenylpropyl)-L-alanyl)-, (S)-
L-Proline, N-((1S)-1-(ethoxycarbonyl)-3-phenylpropyl)-L-alanyl-
L-Proline, N-[(1S)-1-(ethoxycarbonyl)-3-phenylpropyl]-L-alanyl-
LS-190651
MolPort-002-885-877
N-(1(S)-Ethoxycarbonyl-3-phenylpropyl)-L-alanyl-L-proline
N-[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]-L-alanyl-L-proline
N-[1-(S)-ethoxycarbonyl-3-phenylpropyl]-L-alanyl-L-proline
N-{(1S)-1-[(ethyloxy)carbonyl]-3-phenylpropyl}-L-alanyl-L-proline
Nalpha -[(S)-1-ethoxycarbonyl-3-phenylpropyl]-L-alanyl-L-proline
NCGC00016932-01
NCGC00021569-04
NCGC00021569-05
NCGC00021569-06
NCGC00021569-09
NINDS_000408
Prestwick3_000314
PRO106
SBI-0051691.P002
SC-17520
SC-76440
SCHEMBL18
SPBio_001349
Spectrum_001307
Spectrum2_001455
Spectrum3_001478
Spectrum4_000008
Spectrum5_001107
Tox21_110872
Tox21_110872_1
UNII-69PN84IO1A
Vasotec
ZINC3791297

US Patents and Regulatory Information for EPANED

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Silvergate Pharms EPANED enalapril maleate SOLUTION;ORAL 208686-001 Sep 20, 2016 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Silvergate Pharms EPANED KIT enalapril maleate FOR SOLUTION;ORAL 204308-001 Aug 13, 2013 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Silvergate Pharms EPANED enalapril maleate SOLUTION;ORAL 208686-001 Sep 20, 2016 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Silvergate Pharms EPANED KIT enalapril maleate FOR SOLUTION;ORAL 204308-001 Aug 13, 2013 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Silvergate Pharms EPANED KIT enalapril maleate FOR SOLUTION;ORAL 204308-001 Aug 13, 2013 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Paragraph IV (Patent) Challenges for EPANED
Drugname Dosage Strength RLD Date
➤ Subscribe Oral Solution 1 mg/mL ➤ Subscribe ➤ Try a Free Trial
➤ Subscribe Powder for Oral Solution 1 mg/mL ➤ Subscribe ➤ Try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
US Department of Justice
Mallinckrodt
AstraZeneca
Farmers Insurance
Merck
Medtronic
QuintilesIMS
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.